Literature DB >> 3299680

Immunological properties of antigen 60 of BCG. Induction of humoral and cellular immune reactions.

C Cocito, M C Baelden, C Benoit.   

Abstract

Antigen 60 (A60), a member of the thermostable macromolecular antigen family (TMA) and main component of old tuberculin and purified protein derivative (PPD), has been purified from the cytoplasm of Mycobacterium bovis BCG; its structure and metabolism have already been described. In the present paper, the action of A60 on humoral immunity has been analysed by an ELISA type immunoassay, and that on cellular immunity by the mouse footpad swelling test. Injection of very low A60 doses into unprimed mice produced an undetectable level of anti-A60 antibodies; the effect of a booster inoculation was not appreciable in the absence of incomplete Freund's adjuvant, but was evident when the latter was added. Higher doses of the antigen produced an appreciable primary response, and a sharp and long-lasting secondary response, which had a 10-fold higher intensity in the presence of incomplete adjuvant. No detectable delayed hypersensitivity reactions were observed in unprimed mice after footpad injection of A60, whereas clear responses were elicited in primed mice. This effect was more pronounced when the footpad was injected after a secondary response than after a primary response, and it was invariably magnified by incomplete adjuvant. It is concluded that A60 is a powerful immunogen, which is able to induce primary and secondary responses and delayed hypersensitivity reactions, effects that are adjuvant-modulated and develop concurrently.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3299680     DOI: 10.1111/j.1365-3083.1987.tb01084.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  22 in total

1.  Public health application of a serological test for tuberculosis: study of the incidence of inapparent infections among the employees of an Alsatian supermarket.

Authors:  C Wirrmann
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

2.  Intrathecal synthesis of anti-mycobacterial antibodies in patients with tuberculous meningitis. An immunoblotting study.

Authors:  C J Sindic; D Boucquey; M P Van Antwerpen; M C Baelden; C Laterre; C Cocito
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

3.  Immunization of mice with the antigen A60 of Mycobacterium bovis BCG.

Authors:  R D Hubbard; C M Flory; F M Collins; C Cocito
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

4.  Evaluation of the avidity of IgG anti-mycobacterial antibodies in tuberculous patients serum by an A-60 immunoassay.

Authors:  R F Maes
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

5.  Composition and immunogenicity of the polysaccharide components of the thermostable macromolecular antigen group of mycobacterial antigens.

Authors:  M Bruneteau; J Perret; F Vanlinden; G Michel; C Cocito
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

6.  Humoral immune response against antigen 60 in BCG-vaccinated infants.

Authors:  S Rota; U Beyazova; T Karsligil; C Cevheroğlu
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

7.  Subcellular localisation and sedimentation behaviour of antigen 60 from Mycobacterium bovis BCG.

Authors:  C Cocito; F Vanlinden
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

8.  Serodiagnosis survey of tuberculosis by a new ELISA method.

Authors:  E Gulletta; M Del Pezzo; A Sanduzzi; F Bariffi; I Covelli
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

9.  Clinical usefulness of serological measurements obtained by antigen 60 in mycobacterial infections: development of a new concept.

Authors:  R Maes
Journal:  Klin Wochenschr       Date:  1991-10-02

10.  Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.

Authors:  T S van der Werf; P K Das; D van Soolingen; S Yong; T W van der Mark; R van den Akker
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.